8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Elucidation and therapeutic application of the receptor family of S100A8/A9 that controls cancer sensing mechanism of its transition to destination organ

      Impact
      Science Impact, Ltd.

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Metastasis, a process in which cancer cells disseminate around the body from the initial disease site, is perhaps the single most critical determiner in assessing the prognosis for a cancer patient. Due to the propensity for the cancer to then spread and invade other tissues, patients whose cancer has metastasised have a much lower survival rate, with nearly 50 per cent of patients dying within five years. Due to its malignant characteristics, metastasis is considered to be one of the most problematic processes in cancer management and therapeutics, often requiring alternative approaches to control and regulate it. Metastatic behaviour varies depending on the type of tissue from which the cancer originates, and metastatic cancer cells often show a preference for particular target tissues to invade. This phenomenon – the ‘seed and soil’ theory – has been extensively reported in oncological studies and describes how the cancer cell ‘seeds’ grow faster in certain ‘soils’ or tissues. The author and his team seek to develop a neutralising antibody and decoy for the S100A8/A9 receptor family, as an extension of the original project. Further profiling and study of the significance of S100A8/A9 and its receptors in other cancer mechanisms will continue until March 2018, after which Sakaguchi will collaborate with experts in therapeutic proteins assessment and preparation consider exploring therapeutic options. ‘We will propose plans based on our achievements and studies so far, and hope to design neutralising and diagnostic antibodies, such as organ-specific SSSRs, extracellular domain-Fc fusion proteins, for all 20 kinds of S100 proteins,’ reveals Sakaguchi. ‘We have already developed the methods to produce functional antibodies to S100 proteins and assessments of the effects of antibody on organ-specific metastasis inhibition. From these studies, we will next turn the antibody into human chimera antibodies for clinical application,’

          Related collections

          Author and article information

          Journal
          Impact
          impact
          Science Impact, Ltd.
          2398-7073
          June 15 2018
          June 15 2018
          : 2018
          : 3
          : 16-18
          Article
          10.21820/23987073.2018.3.16
          532b037b-b21b-433f-b016-80a7b1a70bf6
          © 2018

          This work is licensed under a Creative Commons Attribution 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/


          Earth & Environmental sciences,Medicine,Computer science,Agriculture,Engineering
          Earth & Environmental sciences, Medicine, Computer science, Agriculture, Engineering

          Comments

          Comment on this article